Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs

SIMPLE SUMMARY: Cancer patients undergoing active treatment may be more vulnerable to COVID-19 due to the effects of the malignant disease and the anti-cancer treatment. Assessing COVID-19 vaccine efficacy in protecting these patients from SARS-CoV-2 infection, is important due to the worldwide pand...

Descripción completa

Detalles Bibliográficos
Autores principales: Agbarya, Abed, Sarel, Ina, Ziv-Baran, Tomer, Agranat, Sivan, Schwartz, Orna, Shai, Ayelet, Nordheimer, Sharon, Fenig, Shlomit, Shechtman, Yelena, Kozlener, Ella, Taha, Tarek, Nasrallah, Haitam, Parikh, Roma, Elkoshi, Nadav, Levy, Carmit, Khoury, Rasha, Brenner, Ronen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391288/
https://www.ncbi.nlm.nih.gov/pubmed/34439346
http://dx.doi.org/10.3390/cancers13164191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391288/
https://www.ncbi.nlm.nih.gov/pubmed/34439346
http://dx.doi.org/10.3390/cancers13164191

Ejemplares similares